These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1080 related items for PubMed ID: 16442246

  • 21. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 24. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 25. The match between adhesive mixture powder formulations for inhalation and the inhaler device.
    Thalberg K, Ahmadi R, Stuckel J, Elfman P, Svensson M.
    Eur J Pharm Sci; 2023 Jul 01; 186():106457. PubMed ID: 37116546
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation.
    Handoko A, Ian L, Peter SJ.
    Eur J Pharm Sci; 2009 Feb 15; 36(2-3):265-74. PubMed ID: 18996188
    [Abstract] [Full Text] [Related]

  • 29. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S, Schoenbrodt T, Weiler C, Friess W.
    Eur J Pharm Sci; 2011 May 18; 43(1-2):32-40. PubMed ID: 21440061
    [Abstract] [Full Text] [Related]

  • 30. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 31. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH, Danède F, Descamps M, Flament MP.
    Eur J Pharm Biopharm; 2008 Sep 15; 70(1):380-8. PubMed ID: 18504120
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Kussendrager KD, Frijlink HW.
    Int J Pharm; 2003 Jul 24; 260(2):201-16. PubMed ID: 12842340
    [Abstract] [Full Text] [Related]

  • 36. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM, Wood O, Ooi J, Traini D.
    Int J Pharm; 2011 Sep 15; 416(1):129-35. PubMed ID: 21708238
    [Abstract] [Full Text] [Related]

  • 37. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation.
    Sebti T, Amighi K.
    Eur J Pharm Biopharm; 2006 May 15; 63(1):51-8. PubMed ID: 16380243
    [Abstract] [Full Text] [Related]

  • 38. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G.
    Int J Pharm; 2009 Oct 01; 380(1-2):80-8. PubMed ID: 19596428
    [Abstract] [Full Text] [Related]

  • 39. Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology.
    Hassan MS, Lau R.
    Int J Pharm; 2011 Jul 15; 413(1-2):93-102. PubMed ID: 21540087
    [Abstract] [Full Text] [Related]

  • 40. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP, Marriott C, Zeng XM.
    Pharm Res; 2007 Feb 15; 24(2):361-9. PubMed ID: 17177114
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.